Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19.
Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19.
复制标题
DOI:
10.1111/dar.13522
复制
发表时间:
2022-11
影响因子:
3.8
通讯作者:
Wu, Li-Tzy
中科院分区:
文献类型:
--
作者:
Subica, Andrew M.;Guerrero, Erick G.;Martin, Tammy K. K.;Okamoto, Scott K.;Aitaoto, Nia;Moss, Howard B.;Morey, Brittany N.;Wu, Li-Tzy
关键词:
Before COVID-19, Native Hawaiians/Pacific Islanders (NH/PI) endured a heavy burden of alcohol, tobacco and other drug (ATOD) use in prior US data. Responding to reports that many NH/PI communities experienced severe COVID-19 disparities that could exacerbate their ATOD burden, we partnered with NH/PI communities to assess the substance use patterns and treatment needs of diverse NH/PIs during COVID-19. Collaborating with NH/PI community organisations across 5 states with large NH/PI populations, we conducted a large-scale investigation of NH/PI ATOD use, mental health and treatment need during COVID-19. Between April-November 2021, NH/PI-heritage research staff from our community partners collected data involving 306 NH/PI adults using several community-based recruitment methods (e-mail, telephone, in-person) and two survey approaches: online and paper-and-pencil. Multivariate regressions were conducted to examine potential predictors of NH/PI alcohol use disorder and need for behavioural health treatment. During COVID-19, 47% and 22% of NH/PI adults reported current alcohol and cigarette use, while 35% reported lifetime illicit substance use (e.g., cannabis, opioid). Depression and anxiety were high, and alcohol use disorder, major depression and generalised anxiety disorder prevalence were 27%, 19% and 27%, respectively. One-third of participants reported past-year treatment need with lifetime illicit substance use, COVID-19 distress and major depression respectively associating with 3.0, 1.2, and 5.3 times greater adjusted odds for needing treatment. NH/PI adults reported heavy ATOD use, depression, anxiety and treatment need during COVID-19. Targeted research and treatment services may be warranted to mitigate COVID-19’s negative behavioural health impact on NH/PI communities.
登录
查看更多内容
影响因子:
3.4
作者:
Garabiles, Melissa R.;Lao, Chao Kei;Hall, Brian J.
通讯作者:
Hall, Brian J.
DOI:
10.15585/mmwr.mm6948a2
发表时间:
2020-12-04
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Center KE;Da Silva J;Hernandez AL;Vang K;Martin DW;Mazurek J;Lilo EA;Zimmerman NK;Krow-Lucal E;Campbell EM;Cowins JV;Walker C;Dominguez KL;Gallo B;Gunn JKL;McCormick D;Cochran C;Smith MR;Dillaha JA;James AE
通讯作者:
James AE
影响因子:
12.7
作者:
Hatzenbuehler, Mark L.;Phelan, Jo C.;Link, Bruce G.
通讯作者:
Link, Bruce G.
影响因子:
--
作者:
Bush, K;Kivlahan, DR;Bradley, KA
通讯作者:
Bradley, KA
DOI:
10.15585/mmwr.mm6946a4
发表时间:
2020-11-20
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Cornelius ME;Wang TW;Jamal A;Loretan CG;Neff LJ
通讯作者:
Neff LJ